RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
Ese artículo me tocó cribarlo a mí. Lo incluí en la lista por el notable aporte de datos que supone.
RT @r_trainer: @influenzer3 https://t.co/K7QMBDkGA1 新型コロナによるギラン・バレー症候群の発症。 https://t.co/j9uwmJcEdL 心血管系疾患、高血圧患者さんに対するACE阻害薬の有益情報。
RT @r_trainer: @influenzer3 https://t.co/K7QMBDkGA1 新型コロナによるギラン・バレー症候群の発症。 https://t.co/j9uwmJcEdL 心血管系疾患、高血圧患者さんに対するACE阻害薬の有益情報。
RT @r_trainer: @influenzer3 https://t.co/K7QMBDkGA1 新型コロナによるギラン・バレー症候群の発症。 https://t.co/j9uwmJcEdL 心血管系疾患、高血圧患者さんに対するACE阻害薬の有益情報。
RT @DrEkstrom: En av flera studier nu som inte visar på någon korrelation mellan användande av vissa blodtryckssänkande läkemedel (ACE-hämm…
RT @meed_ref: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. https://t.co/pEc7YgqcJ3 -Included at COVID-19 & MEED CV DI…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. https://t.co/pEc7YgqcJ3 -Included at COVID-19 & MEED CV DISEASE https://t.co/HJyKalLaLq #MeedCOVID19 @MRMehraMD @secardiologia https://t.co/jxX6EfMIzZ
@borasam @hugorifkind The NEJM says the contrary https://t.co/lPpL5M828t "The factors we found to be independently associated with an increased risk of in-hospital death were (...) current smoking (9.4%, vs. 5.6% among former smokers or nonsmokers; odds ra
RT @Wdekanter: RT Factors found to be independently associated with an increased risk of in-hospital death: age, COPD, smoking: #corona…
RT @r_trainer: @influenzer3 https://t.co/K7QMBDkGA1 新型コロナによるギラン・バレー症候群の発症。 https://t.co/j9uwmJcEdL 心血管系疾患、高血圧患者さんに対するACE阻害薬の有益情報。
@influenzer3 https://t.co/K7QMBDkGA1 新型コロナによるギラン・バレー症候群の発症。 https://t.co/j9uwmJcEdL 心血管系疾患、高血圧患者さんに対するACE阻害薬の有益情報。
More evidence that — contrary to some recent counterintuitive research — smoking does not protect against #covid19.
RT @plopnl: @liorakern @WHO @Wdekanter High blood pressure, cholesterol, diabetes, and obesity not checked? Smokers have increased risk whe…
RT @vass_vassiliou: Multiple articles @NEJM on cardiovascular and #covid - certainly ACE I / ARB are faring well! https://t.co/k1cxFkuDAP &…
@hustendoktor @baschdi @ApothekerDer Da hast Du Recht 🧐 @spektrum Zum Thema ACE Hemmer... Mein aktueller Stand der letzten „Studien“ dass unter ACE Hemmern keine schwererer Krankheitsverlauf zu erwarten ist. https://t.co/xFT8B6J4tN https://t.co/S0T8iIXb
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @DrMelodyDing: OK, very timely update from @NEJM today based on data from 169 hospitals from many countries: among hospitalised #COVID19…
OK, very timely update from @NEJM today based on data from 169 hospitals from many countries: among hospitalised #COVID19 patients, smokers were more likely to die. @AdrianBauman https://t.co/dMCrjgWBtk
RT @ProfEdwardsNZ: Important study from Mehra et al in NEJM on risk factors for death in 8910 patients hospitalised with COVID-19 in 11 cou…
RT @vass_vassiliou: Multiple articles @NEJM on cardiovascular and #covid - certainly ACE I / ARB are faring well! https://t.co/k1cxFkuDAP &…
#Cardiovascular Disease, #Drug Therapy, and #Mortality in Covid-19 | NEJM @vadivale #ACEI #ARB https://t.co/B36SEIHoyg
https://t.co/QcXHEsPiG3 NEJM says smokers face double the risk of nonsmokers.
心血管系合併症は死亡リスクあげるけれど、(当初懸念された)ACE阻害剤やARB(←血圧の薬)はそうでもなかった報告 Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/TUxFJemBFO #COVID-19 #SARS-CoV-2 #2019-nCoV #武漢肺炎 #新型コロナウイルス
RT @SIAC_cardio: Estudio reciente de @NEJM 8910 pts con #COVID19 (Dic - Marzo) - 5,8% ☠️ -Edad y enf. CV⏩factores asociados a mortalidad…
@JCMorenoGarcia @McRattity As a uni student, you should know better to make comments without evidence. I’m specifically talking about link between hypertension, ace inhibitors and COVID 19. https://t.co/jbWDSgcgrY
lo aclaran aquí: https://t.co/62eUe1uZNf hay riesgo con enfermedades cardiovasculares, como si yo supiera que engloba eso... pero no con la medicación... eso es algo vago... no con la medicación? eso no es decir no con la hipertensión... leer de nuevo...
@MFrank_44 @RobertLKruse Observational studies so far point in direction of no effect on mortality rates. Examples: https://t.co/LXHZUvGP2q https://t.co/VqPlO0qUHz For a full overview: https://t.co/1CWMI3Udvs
RT @toyosh: 心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。 https://t.co/QRCGmFg…
NEJM published report confirm of the independent relationship of older age, underlying cardiovascular disease (coronary artery disease, heart failure, and cardiac arrhythmias), current smoking, and COPD with death in Covid-19. https://t.co/Sd1IbSONlC #Indi
@liorakern @WHO @Wdekanter High blood pressure, cholesterol, diabetes, and obesity not checked? Smokers have increased risk when things go pear shaped, with just 5.5% they are underrepresented.🤔 How could they mis the fact upto 47% had multiple conditions?
RT @toyosh: 心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。
RT @AssalaLamaa: تظهر هذه الدراسة التي نشرت في NEJM@ أن التدخين يزيد من احتمالات الموت عند المصابين بال #كوفيد_١٩ بالنسبة لغير المدخنين أو…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 [May 1, 2020] @MRMehraMD et al. @NEJM https://t.co/w4eJR46pZb #2019nCoV #COVID19 #CCC19
RT @ProfEdwardsNZ: Important study from Mehra et al in NEJM on risk factors for death in 8910 patients hospitalised with COVID-19 in 11 cou…
Important study from Mehra et al in NEJM on risk factors for death in 8910 patients hospitalised with COVID-19 in 11 countries and 169 hospitals. Increased risk (1.79) of death among current smokers after adjusting for co-morbid conditions (CHD, COPD etc).
RT @Hugolpi: https://t.co/yRPPmenkEu Thanks @NEJM and authors of the study. Now the picture is clearer: Risk of death in COVID19 is 79% hi…
@FredLAFernandes @Karl_MD Saiu um NEJM sobre algumas características clinicas de pacientes que morrem com #COVID19. Fumante tem 80% mais chance de morrer. https://t.co/3dacTAD2Ch
Principales candidatos a receptores de vacunas #covid19 por mayor mortalidad: @NEJM >65 años Enfermedad coronaria Insuficiencia cardiaca Arritmia Tabaquismo https://t.co/oe89pkDT9t https://t.co/qwrPqpvW1e
Interesting article in @NEJM on the role of ACE inhibitors and ARBs in severe cases of Covid-19: https://t.co/IFynnesBzm
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @oromiaphysician: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/MPW8A8whFA
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/MPW8A8whFA
RT @EmilioAlegre1: Análisis multivariante con 9000 pacientes. Tomar IECA para enfermedad cardiovascular no perjudica si se sufre COVID-19,…
RT @saludydoshuevos: Una epidemia y dos huevos duros Mito 1 La hipertensión es un factor de riesgo para fallecer por Covid19. No parece ht…
@TimmKlotzek @wolflotter Vorallem das Gehirn ist betroffen. 99,5% IFR - so auch beim Autor der SZ, der in die Studie was hineininterpretiert, das so sicher nicht drin steht ... 🙄 #panikmache https://t.co/xcKijMeXJh
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @vass_vassiliou: Multiple articles @NEJM on cardiovascular and #covid - certainly ACE I / ARB are faring well! https://t.co/k1cxFkuDAP &…
RT @Steph__A__: Base de données: 169 hôpitaux en Asie, en Europe et en Amérique du Nord. 8910 patients #COVID19 pour lesquels l'état de sor…
RT @EmilioAlegre1: Análisis multivariante con 9000 pacientes. Tomar IECA para enfermedad cardiovascular no perjudica si se sufre COVID-19,…
RT @ValdivielsoP: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/P4P8OZei6G Aunque es un estudio obser…
RT @EmilioAlegre1: Análisis multivariante con 9000 pacientes. Tomar IECA para enfermedad cardiovascular no perjudica si se sufre COVID-19,…
RT @mtmdphd: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 [May 1, 2020] @MRMehraMD et al. @NEJM https://t.co/w4eJR46pZb…
RT @vass_vassiliou: Multiple articles @NEJM on cardiovascular and #covid - certainly ACE I / ARB are faring well! https://t.co/k1cxFkuDAP &…
RT @BulentTutluoglu: Yüksek tansiyonu olup ACE inhibitörü tansiyon ilacı kullananlarda tansiyon ilacını değiştirmeye gerek yok . Şüpheleri…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 https://t.co/Kq6K6lVBlY Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 https://t.co/oKpWO7y8Dg Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 ht
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @ernestocardio: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/I4ljIVGkB6 @mencardio @torresviera @…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @hahn_rt: Hot off the @NEJM press Cardiovascular Disease, Drug Therapy, and Mortality in #COVID__19 https://t.co/no5ZTfTAbp ACEI associa…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
RT @AssalaLamaa: تظهر هذه الدراسة التي نشرت في NEJM@ أن التدخين يزيد من احتمالات الموت عند المصابين بال #كوفيد_١٩ بالنسبة لغير المدخنين أو…
RT @DocteurJuneau: Voici un des articles qui montre que les IECA et ARA ne sont pas associés à un mauvais pronostic en cas de COVID19.Car…
New research on ACE2 activating Hypertension meds ARB & ACEI in relation to COVid. Thread:
RT @hswapnil: Big update on #NephJC #COVIDACE2 page Link https://t.co/vwnT0YMkQw Added the three NEJM studies: Mehra: https://t.co/mMPCZb…
RT @hswapnil: Big update on #NephJC #COVIDACE2 page Link https://t.co/vwnT0YMkQw Added the three NEJM studies: Mehra: https://t.co/mMPCZb…
RT @hswapnil: Big update on #NephJC #COVIDACE2 page Link https://t.co/vwnT0YMkQw Added the three NEJM studies: Mehra: https://t.co/mMPCZb…
RT @Saludteca: #AyudaBiblioteca Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 https://t.co/EonnxeK8KM
RT @mtmdphd: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 [May 1, 2020] @MRMehraMD et al. @NEJM https://t.co/w4eJR46pZb…
Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 [May 1, 2020] @MRMehraMD et al. @NEJM https://t.co/w4eJR46pZb #2019nCoV #COVID19 #CCC19 n=8910. No harmful association of ACE inhibitors or ARB https://t.co/FVKgemyde6
RT @vass_vassiliou: Multiple articles @NEJM on cardiovascular and #covid - certainly ACE I / ARB are faring well! https://t.co/k1cxFkuDAP &…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @rincondesisifo: (NEJM) 3 estudios no encuentran daño asociado al uso de IECA o ARA2 en pac con #COVID19 https://t.co/iRJa5x9CPQ Est Obs…
RT @toyosh: 心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。
Voici un des articles qui montre que les IECA et ARA ne sont pas associés à un mauvais pronostic en cas de COVID19.Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 | NEJM https://t.co/LKAr0KgW5l
RT @ProfJDChalmers: Landmark day in the epidemiology of COVID- the day that an observational study shows an extreme beneficial effect of st…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @toyosh: 心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。
RT @toyosh: 心血管系疾患、高血圧患者さんに対するACE阻害薬は、#COVID19 に対して、少なくとも有害ではない(むしろ有益)という大規模な観察研究がNEJMからpublishされました。懸念を払拭出来たことは大きいです。
RT @Neuro24de: @TheEconomist Patients who died were also more likely to have had COPD and a history of current smoking. https://t.co/c7Yj1…
RT @mayogastro: Padecer de enfermedad cardiovascular es el factor de riesgo más importante de severidad en CoViD-19. Cuidados extremos en e…
RT @rincondesisifo: (NEJM) 3 estudios no encuentran daño asociado al uso de IECA o ARA2 en pac con #COVID19 https://t.co/iRJa5x9CPQ Est Obs…
RT @naoyainfection: COVID-19における心血管疾患、薬物治療、死亡率 https://t.co/F5fjCzTYN5… ・COVID-19患者においてARB、ACE-Iと院内死亡リスクとの関連は認められなかった。 ・むしろACE-Iとスタチンについて…
RT @EmilioAlegre1: Análisis multivariante con 9000 pacientes. Tomar IECA para enfermedad cardiovascular no perjudica si se sufre COVID-19,…
RT @EmilioAlegre1: Análisis multivariante con 9000 pacientes. Tomar IECA para enfermedad cardiovascular no perjudica si se sufre COVID-19,…
RT @Dr_Lander: Changing thoughts regarding ACEI/ARB in #COVID19 .@NJACC. https://t.co/UhyHzqaqUl
RT @EricTopol: Remember the early hysteria about ACE inhibitors putting patients w/ #COVID19 at risk? That was a wrong turn. 3 new @NEJM ap…
RT @SreyRam: Our @NEJM study of 8,910 patients from 169 hospitals in Asia, Europe & North America showed #cardiovascular dx, #smoking & #CO…
RT @SreyRam: Our @NEJM study of 8,910 patients from 169 hospitals in Asia, Europe & North America showed #cardiovascular dx, #smoking & #CO…
RT @Neuro24de: @TheEconomist Patients who died were also more likely to have had COPD and a history of current smoking. https://t.co/c7Yj1…
RT @JSheltzer: New data in @NEJM: smoking increases your chances of dying from #COVID19 by 80%. If you have COPD, COVID19 mortality is trip…
@SebastienBZ @addict38 @couteronjp @parissanstabac @FedeAddiction @FFAddictologie @Addict_Aide @JeNeFumePlus @respadd @FarsalinosK Rien de préciser sur une substitution en nicotine pour les fumeurs en USI. Si on ne s'en tient pas au titre - pas très transp